16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis
Clinical trial NCT01649375 · COMPLETED
Trial details
- NCT number
- NCT01649375
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-18
- Primary completion
- 2014-08-04
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.